InsiderClue
Stocks · Health care · Pharmaceutical Preparations

ANAPTYSBIO, INC

ANAB Clue Score43
United States Fiscal year ends June CIK 0001370053
$45.95 -0.56% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $45.95 +61.57% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 26 Jan 2017. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue16.7Operating income−3.0Net income−4.3EPS, diluted−1.62Fiscal year 2017Revenue10.0 −40.1%Operating income−28.8Net income−30.1EPS, diluted−1.52Fiscal year 2018Revenue5.0 −50.0%Operating income−66.7Net income−61.7EPS, diluted−2.50Fiscal year 2019Revenue8.0 +60.0%Operating income−107.4Net income−97.3EPS, diluted−3.60Fiscal year 2020Revenue75.0 +837.5%Operating income−23.9Net income−19.9EPS, diluted−0.73Fiscal year 2021Revenue63.2 −15.8%Operating income−56.8Net income−57.8EPS, diluted−2.11Fiscal year 2022Revenue10.3 −83.7%Operating income−115.2Net income−128.7EPS, diluted−4.57Fiscal year 2023Revenue17.2 +66.8%Operating income−164.4Net income−163.6EPS, diluted−6.08Fiscal year 2024Revenue91.3 +432.0%Operating income−114.9Net income−145.2EPS, diluted−5.12Fiscal year 2025Revenue234.6 +157.0%Operating income47.9Net income−13.2EPS, diluted−0.46
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 16.7 10.0 5.0 8.0 75.0 63.2 10.3 17.2 91.3 234.6
Growth −40.1% −50.0% +60.0% +837.5% −15.8% −83.7% +66.8% +432.0% +157.0%
Operating income −3.0 −28.8 −66.7 −107.4 −23.9 −56.8 −115.2 −164.4 −114.9 47.9
Net income −4.3 −30.1 −61.7 −97.3 −19.9 −57.8 −128.7 −163.6 −145.2 −13.2
Growth
EPS, diluted −1.62 −1.52 −2.50 −3.60 −0.73 −2.11 −4.57 −6.08 −5.12 −0.46
Growth

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2016Operating margin−18.1%Net margin−25.5%Free cash flow margin−54.4%Fiscal year 2017Operating margin−287.8%Net margin−300.7%Free cash flow margin−197.3%Fiscal year 2018Operating margin−1,334.4%Net margin−1,233.1%Free cash flow margin−991.4%Fiscal year 2019Operating margin−1,342.9%Net margin−1,216.7%Free cash flow margin−879.0%Fiscal year 2020Operating margin−31.8%Net margin−26.6%Free cash flow margin−19.6%Fiscal year 2021Operating margin−89.9%Net margin−91.5%Free cash flow margin−74.8%Fiscal year 2022Operating margin−1,119.4%Net margin−1,251.3%Free cash flow margin−718.9%Fiscal year 2023Operating margin−958.3%Net margin−953.7%Free cash flow margin−708.8%Fiscal year 2024Operating margin−125.9%Net margin−159.1%Free cash flow margin−148.7%Fiscal year 2025Operating margin20.4%Net margin−5.6%Free cash flow margin8.4%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin −18.1% −287.8% −1,334.4% −1,342.9% −31.8% −89.9% −1,119.4% −958.3% −125.9% 20.4%
Net margin −25.5% −300.7% −1,233.1% −1,216.7% −26.6% −91.5% −1,251.3% −953.7% −159.1% −5.6%
Free cash flow margin −54.4% −197.3% −991.4% −879.0% −19.6% −74.8% −718.9% −708.8% −148.7% 8.4%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−9.0Capital expenditure−0.1Free cash flow−9.1Buybacks−0.0Fiscal year 2017Operating cash flow−19.4Capital expenditure−0.3Free cash flow−19.7Buybacks0.0Fiscal year 2018Operating cash flow−48.5Capital expenditure−1.1Free cash flow−49.6Buybacks0.0Fiscal year 2019Operating cash flow−69.5Capital expenditure−0.8Free cash flow−70.3Fiscal year 2020Operating cash flow−14.2Capital expenditure−0.6Free cash flow−14.7Fiscal year 2021Operating cash flow−45.9Capital expenditure−1.4Free cash flow−47.3Buybacks0.0Fiscal year 2022Operating cash flow−73.6Capital expenditure−0.4Free cash flow−74.0Buybacks0.0Fiscal year 2023Operating cash flow−120.8Capital expenditure−0.8Free cash flow−121.6Buybacks−50.0Fiscal year 2024Operating cash flow−135.3Capital expenditure−0.4Free cash flow−135.7Buybacks−0.5Fiscal year 2025Operating cash flow19.7Capital expenditure−0.1Free cash flow19.6Buybacks−68.6
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −9.0 −19.4 −48.5 −69.5 −14.2 −45.9 −73.6 −120.8 −135.3 19.7
Capital expenditure −0.1 −0.3 −1.1 −0.8 −0.6 −1.4 −0.4 −0.8 −0.4 −0.1
Free cash flow −9.1 −19.7 −49.6 −70.3 −14.7 −47.3 −74.0 −121.6 −135.7 19.6
Growth
Buybacks −0.0 0.0 0.0 n/a n/a 0.0 0.0 −50.0 −0.5 −68.6

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2016Cash51.2Shareholders’ equity−38.2Fiscal year 2017Cash81.2Shareholders’ equity307.6Fiscal year 2018Cash113.6Shareholders’ equity486.4Fiscal year 2019Cash171.0Shareholders’ equity405.0Fiscal year 2020Cash250.5Shareholders’ equity396.7Fiscal year 2021Cash495.7Shareholders’ equity356.4Fiscal year 2022Cash71.3Shareholders’ equity262.1Fiscal year 2023Cash36.0Shareholders’ equity88.1Fiscal year 2024Cash123.1Shareholders’ equity70.9Fiscal year 2025Cash238.2Shareholders’ equity37.2
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 51.2 81.2 113.6 171.0 250.5 495.7 71.3 36.0 123.1 238.2
Shareholders’ equity −38.2 307.6 486.4 405.0 396.7 356.4 262.1 88.1 70.9 37.2

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
16.7 10.0 5.0 8.0 75.0 63.2 10.3 17.2 91.3 234.6
Growth −40.1% −50.0% +60.0% +837.5% −15.8% −83.7% +66.8% +432.0% +157.0%
15.4 29.4 56.2 99.3 80.0 98.5 88.8 n/a n/a n/a
4.3 9.3 15.5 16.1 18.9 21.5 36.6 41.9 42.4 50.7
−3.0 −28.8 −66.7 −107.4 −23.9 −56.8 −115.2 −164.4 −114.9 47.9
Growth
−4.3 −30.1 −61.8 −97.5 −19.9 −57.8 −128.7 −163.6 −145.2 −13.1
0.0 0.0 −0.2 −0.2 0.0 0.0 0.0 −0.0 0.0 0.2
−4.3 −30.1 −61.7 −97.3 −19.9 −57.8 −128.7 −163.6 −145.2 −13.2
Growth
Per share
−1.62 −1.52 −2.50 −3.60 −0.73 −2.11 −4.57 −6.08 −5.12 −0.46
−1.62 −1.52 −2.50 −3.60 −0.73 −2.11 −4.57 −6.08 −5.12 −0.46
Growth
n/a n/a n/a 27.1 27.3 27.4 28.2 26.9 28.4 28.8
n/a n/a n/a 27.1 27.3 27.4 28.2 26.9 28.4 28.8
Growth +0.9% +0.5% +2.7% −4.4% +5.4% +1.3%

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 25.6% a year over five years.
  • The diluted share count rose 5.3% in five years, which is dilution.
  • Operating margin is up 52.3 points on five years ago, at 20.4%.
  • A net loss in 10 of 10 years on file.